Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Blood Cancer Journal
|
April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma
L F Porrata, K M Ristow, T M Habermann, et al.
American Journal of Hematology
|
January 13, 2015
Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma
Sameer A Parikh, Thomas M Habermann, Kari G Chaffee, et al.
American Journal of Hematology
|
December 6, 2018
Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018
Alessia Castellino, Jose S Pulido, Patrick B Johnston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2006
Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis
Ted R Mikuls, Justin O Endo, Susan E Puumala, et al.
Hemasphere
|
September 13, 2021
Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria
Rebecca L King, Arushi Khurana, Raphael Mwangi, et al.
Blood
|
February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
Saad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
British Journal of Haematology
|
May 4, 2017
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma
Narendranath Epperla, Anthony Q Pham, Brian L Burnette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2013
Bowel perforation in intestinal lymphoma: incidence and clinical features
R Vaidya, T M Habermann, J H Donohue, et al.
Blood
|
June 5, 2014
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R Parrilla Castellar, Elaine S Jaffe, Jonathan W Said, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Blood Cancer Journal
|
April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma
L F Porrata, K M Ristow, T M Habermann, et al.
American Journal of Hematology
|
January 13, 2015
Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma
Sameer A Parikh, Thomas M Habermann, Kari G Chaffee, et al.
American Journal of Hematology
|
December 6, 2018
Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018
Alessia Castellino, Jose S Pulido, Patrick B Johnston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2006
Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis
Ted R Mikuls, Justin O Endo, Susan E Puumala, et al.
Hemasphere
|
September 13, 2021
Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria
Rebecca L King, Arushi Khurana, Raphael Mwangi, et al.
Blood
|
February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
Saad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
British Journal of Haematology
|
May 4, 2017
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma
Narendranath Epperla, Anthony Q Pham, Brian L Burnette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2013
Bowel perforation in intestinal lymphoma: incidence and clinical features
R Vaidya, T M Habermann, J H Donohue, et al.
Blood
|
June 5, 2014
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R Parrilla Castellar, Elaine S Jaffe, Jonathan W Said, et al.
Page
of 7